The landscape of hepatitis C (HCV) management has shifted significantly with the recent regulatory approvals of AbbVie’s direct-acting antiviral therapy,…
Read More
Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business
More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, classified psilocybin as a…
Read More
A GLP-1 bone study shows why matching matters in real-world evidence
The burgeoning field of real-world evidence (RWE) is transforming how medical professionals and regulators understand the long-term effects of therapeutics,…
Read More
Mixing evidence and imagination brings three real ancient Romans to life
The ancient Roman city of Pompeii, forever etched in history as a catastrophic tomb, is being re-examined through a new…
Read More
Calderasib’s Real Innovation: Designed for Combinability and Potency Unlocks New Frontiers in KRAS-Mutated Cancers
Merck’s latest investigational drug, calderasib, is not merely another entry into the burgeoning field of KRAS G12C inhibition; it represents…
Read More
Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business
More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…
Read More
A GLP-1 bone study shows why matching matters in real-world evidence
The growing reliance on real-world evidence (RWE) to inform critical healthcare decisions necessitates an unwavering commitment to methodological rigor, a…
Read More
5 Real-World SQL Projects to Build Your Data Portfolio
SQL remains a cornerstone skill for professionals across the data landscape, from data analysts and scientists to business intelligence specialists…
Read More
Calderasib’s real innovation: designed for combinability and potency
Merck has unveiled its investigational KRAS G12C inhibitor, calderasib, positioning it not merely as another potent molecule in a rapidly…
Read More
Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business
The landscape of mental health treatment is on the cusp of a profound transformation, with psilocybin, a compound once relegated…
Read More
